Orion Corporation will publish its Financial Statement Release 2014 on Wednesday, 4 February 2015.
The publication dates of the Interim Reports in 2015 are as follows:
Interim Report January-March 2015 Wednesday, 29 April 2015
Interim Report January-June 2015 Tuesday, 28 July 2015
Interim Report January-September 2015 Tuesday, 27 October 2015
The Financial Statements and the report of the Board of Directors 2014 will be published on the Company's website at the latest in week 10/2015.
The Annual General Meeting is planned to be held on Tuesday, 24 March 2015 in Helsinki.
Orion's financial reports and related presentation material are available on the Group's website at http://www.orion.fi/investors promptly after the publishing. The website also provides a possibility to register on Orion's mailing lists for releases.
| Timo Lappalainen |
President and CEO
| Jari Karlson |
Orionintie 1A, FI-02200 Espoo, Finland
Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. Pharmaceutical R&D focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler® pulmonary drugs.
Orion's net sales in 2013 amounted to EUR 1, 007 million and the company had about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki.